Literature DB >> 28447390

High non-esterified fatty acid concentrations promote expression and secretion of fibroblast growth factor 21 in calf hepatocytes cultured in vitro.

J G Wang1, Y Z Guo1, Y Z Kong1, S Dai1, B Y Zhao1.   

Abstract

Negative energy balance is considered as the pathological basis of energy metabolic disorders in periparturient dairy cows. Serum non-esterified fatty acids (NEFA) are one of the most important indicators of energy balance status. Fibroblast growth factor 21 (FGF21) has been identified as a hepatokine involved in regulation of metabolic adaptations, such as promoting hepatic lipid oxidation and ketogenesis, during energy deprivation. However, the direct effects of NEFA on FGF21 expression and secretion in bovine hepatocytes are not entirely clear. The objective of this study was to investigate the effects of different NEFA concentrations on FGF21 expression and secretion in calf hepatocytes cultured in vitro. NEFA were added to the culture solution at final concentrations of 0.6, 1.2, 1.8 and 2.4 mmol/L. After 24 hr of continuous culture, FGF21 mRNA and protein expression levels in the hepatocytes were determined by real-time PCR and Western blot respectively. FGF21 secretion in the supernatant was determined by enzyme-linked immunosorbent assay (ELISA). The results showed that expression and secretion of FGF21 at 0.6 mmol/L NEFA-treated hepatocytes was higher than that of the control group (p < .05). The FGF21 expression and secretion were similar at 1.2, 1.8 and 2.4 mmol/L NEFA-treated hepatocytes and significantly higher than those observed for controls (p < .01). These data suggest that high concentrations of NEFA significantly promote FGF21 expression and secretion in bovine hepatocytes. In particular, this promotion occurs in a dose-dependent manner and may be involved in the pathological processes of energy metabolism disorders of dairy cows in the peripartum period.
© 2017 Blackwell Verlag GmbH.

Entities:  

Keywords:  dairy cow; hepatocyte; hepatokine; negative energy balance; peripartum period

Mesh:

Substances:

Year:  2017        PMID: 28447390     DOI: 10.1111/jpn.12699

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  4 in total

1.  FGF21 Reduces Lipid Accumulation in Bovine Hepatocytes by Enhancing Lipid Oxidation and Reducing Lipogenesis via AMPK Signaling.

Authors:  Yezi Kong; Chenxu Zhao; Panpan Tan; Siqi Liu; Yan Huang; Fangyuan Zeng; Pingjun Ma; Yazhou Guo; Baoyu Zhao; Jianguo Wang
Journal:  Animals (Basel)       Date:  2022-04-06       Impact factor: 2.752

Review 2.  Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism.

Authors:  Xin Su; Xiang Chen; Hua Peng; Jingjin Song; Bin Wang; Xijie Wu
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

3.  Maternal Fibroblast Growth Factor 21 Levels Decrease during Early Pregnancy in Normotensive Pregnant Women but Are Higher in Preeclamptic Women-A Longitudinal Study.

Authors:  Julieth Daniela Buell-Acosta; Maria Fernanda Garces; Arturo José Parada-Baños; Edith Angel-Muller; Maria Carolina Paez; Javier Eslava-Schmalbach; Franklin Escobar-Cordoba; Sofia Alexandra Caminos-Cepeda; Ezequiel Lacunza; Justo P Castaño; Rubén Nogueiras; Carlos Dieguez; Ariel Iván Ruiz-Parra; Jorge Eduardo Caminos
Journal:  Cells       Date:  2022-07-21       Impact factor: 7.666

4.  Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders.

Authors:  Jianguo Wang; Xiaoyan Zhu; Guanghui She; Yezi Kong; Yazhou Guo; Zhe Wang; Guowen Liu; Baoyu Zhao
Journal:  BMC Vet Res       Date:  2018-08-13       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.